Altimmune Inc 's Total Debt to Equity

ALT's quarterly Total Debt to Equity and Total Debt, Equity growth

In the forth quarter 2023 Altimmune Inc did not have Total Debt.

Within Major Pharmaceutical Preparations industry Altimmune Inc achieved the lowest Total Debt to Equity in the forth quarter 2023. While total ranking remained the same in the forth quarter 2023 compared to the previous quarter at no. .

Explain Debt to Equity Ratio?
What is the structure of ALT´s Total Debt?
How valuable is the ALT´s Equity?

Select the Comparisons :

None ▼

Select the Ratio:

Total Debt to Equity ▼

None ▼

Total Debt to Equity ▼

ALT Total Debt to Equity	(Dec 31 2023) IV. Quarter	(Sep 30 2023) III. Quarter	(Jun 30 2023) II. Quarter	(Mar 31 2023) I. Quarter	(Dec 31 2022) IV. Quarter
Y / Y Equity Change	4.75 %	-26.65 %	-13.79 %	-9.27 %	-6.95 %
Y / Y Total Debt Change	-	-4.46 %	172.94 %	163.79 %	215.02 %
Total Debt to Equity MRQ	-	0.03	0.02	0.03	0.02
ALT's Total Ranking	#	#	#	#	#
Seq. Equity Change	29.06 %	-10.33 %	-0.01 %	-9.48 %	-9.63 %
Seq. Total Debt Change	-	3.36 %	-5.34 %	-3.95 %	1.66 %

New: More ALT's historic Total Debt to Equity Ratios >>

Total Debt to Equity forth quarter 2023 Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	#
Healthcare Sector	#
Overall Market	#

Total Debt to Equity Statistics
High	Average	Low
0	0	0

Financial Statements
Altimmune Inc 's Equity	$ 194 Millions	Visit ALT's Balance sheet
Altimmune Inc 's Total Debt	$ 0 Millions	Visit ALT's Balance sheet
Source of ALT's Sales		Visit ALT's Sales by Geography

Cumulative Altimmune Inc 's Total Debt to Equity

ALT's Total Debt to Equity for the trailling 12 Months

ALT Total Debt to Equity	(Dec 31 2023) IV. Quarter	(Sep 30 2023) III. Quarter	(Jun 30 2023) II. Quarter	(Mar 31 2023) I. Quarter	(Dec 31 2022) IV. Quarter
Y / Y Equity TTM Growth	4.75 %	-26.65 %	-13.79 %	-9.27 %	-6.95 %
Y / Y Total Debt TTM Growth	-	-4.46 %	172.94 %	163.79 %	215.02 %
Total Debt to Equity TTM	0.02	0.03	0.02	0.02	0.02
Total Ranking TTM
Seq. Equity TTM Growth	29.06 %	-10.33 %	-0.01 %	-9.48 %	-9.63 %
Seq. Total Debt TTM Growth	-	3.36 %	-5.34 %	-3.95 %	1.66 %

Debt to equity ratio ranking by company, industry and sector >> Back to ALT Financial Strength Comparisons >> Go to Compare ALT Total Debt to Equity Ratio to its Competitors

On the trailing twelve months basis During the twelve months ending IV Quarter 2023 Altimmune Inc did not have Total Debt .
Total Debt to Equity is the average cumulative value over the last four quarters.

Among companies in the Major Pharmaceutical Preparations industry only one has achieved lower Total Debt to Equity. While total ranking remained unchanged compared to previous 12 month period at no. 12.

Explain Debt to Equity Ratio?
What is the structure of ALT´s Total Debt?
How valuable is the ALT´s Equity?

TTM Total Debt to Equity Company Ranking
Within:	No.
Within the Major Pharmaceutical Preparations Industry	# 2
Healthcare Sector	# 2
Within the Market	#

trailing twelve months Total Debt to Equity Statistics
High	Average	Low
0.11	0.04	0.01
(Jun 30 2018)		(Dec 31 2021)

Companies with similar Total Debt to Equity in the quarter ending Dec 31 2023, within Major Pharmaceutical Preparations Industry

Total Debt to Equity

Dec 31 2023 MRQ Total Debt

Dec 31 2023 MRQ Equity

Date modified: 2024-03-27T23:19:32+00:00

Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com